Enzymotec (ENZY) Misses Q2 EPS by 8c; Cuts FY14 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
Wells Fargo Downgrades Enzymotec (ENZY) to Market Perform
August 6, 2014 7:10 AM EDTWells Fargo downgraded Enzymotec (NASDAQ: ENZY) from Outperform to Market Perform with a price target of $9-$10 (from $26-$28). The change follows Q2 results and guidance.
For an analyst ratings summary and ratings history on Enzymotec... More
Enzymotec Ltd. (ENZY) trading halted with news pending
August 5, 2014 7:25 AM EDTEnzymotec Ltd. (NASDAQ: ENZY) trading halted with news pending.
... More